Lonza to Host Webinar on "Data Integrity for Endotoxin Testing"

Cologne, DE / Walkersville, MD (USA), 28 April 2017 – Lonza is hosting a free 60-minute webinar on 9 May 2017 emphasizing the importance of data integrity for endotoxin testing. With data integrity being a critical area for the endotoxin-testing community, Robert Porzio, Product Manager for Endotoxin Detection at Lonza, will highlight in the webinar different data integrity issues and the tools available to overcome these challenges.

During the webinar, the following topics will be covered:

 

·Data integrity basics and corporate governance from the FDA

·Kinetic testing focusing on observations of subjective test methods

·Data integrity components of the WinKQCL™ Endotoxin Detection & Analysis Software and how these comply with the FDA’s data integrity guidance

·Establishing a risk-based approach to review processes

·Creating a FMEA (Failure Modes and Effects Analysis)

·Document assay process flow from sample preparation to review and release of results

Anyone interested in attending the webinar can register by selecting the following link: http://www.workcast.com/register?cpak=2018538681536495&referrer=pr

 

Date: Tuesday, 9 May 2017, 8 AM PDT (Los Angeles) / 11 AM EDT (New York) / 4 PM BST (London) / 5 PM CEST (Berlin)

Speaker: Robert Porzio, Product Manager for Endotoxin Detection, Lonza Walkersville, Inc.

 

Further information can be found on the Endotoxin Detection product page. Alternatively, by registering interest in the webinar, participants will receive a link once it is available to view “on demand” via the Lonza website.

 

More information about Lonza’s upcoming webinars is available on the following website: www.lonza.com/qcwebinars.  

 

About Lonza

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. It harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life.

 

Not only is Lonza a custom manufacturer and developer, the company also offers services and products ranging from active pharmaceutical ingredients to drinking water sanitizers, from nutritional and personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.

 

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with approximately 40 major manufacturing and R&D facilities and more than 10,000 full-time employees worldwide. The company generated sales of CHF 4.13 billion in 2016 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.

 

Additional Information and Disclaimer

Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.